Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine

Vaccine

Volumn 14, Issue 14, 1996, Pages 1366-1374

  Ma, Jianneng ^a   Hine, Paul M ^b   Clough, Ellen R ^c   Fish, Durland ^d   Coughlin, Richard T ^a   Beltz, Gerald A ^b   Shew, Marvin G ^c  

^a MALLINCKRODT PHARMACEUTICALS   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Calypte Biomedical Corporation   (United States)

^d Shew's Veterinary Clinic   (United States)

Author keywords

Borrelia burgdorferi; Osp canine Lyme disease vaccine efficacy; Tick challenge

Indexed keywords

LYME DISEASE VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG SAFETY; IMMUNOGENICITY; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL; TICK; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BORRELIA BURGDORFERI GROUP; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNE SERA; LYME DISEASE; VACCINES, SYNTHETIC;

EID: 0030266962     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00045-X     Document Type: Article

References (61)

1. Steere, A.C. Lyme disease. N. Engl. J. Med. 1989, 321, 586-596
2. Baranton, G., Postic, D., Saint Girons, I. et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int. J. Sys. Bacteriol. 1992, 42, 378-383
3. Burgdorfer, W., Barbour, A.G., Hayes, S.F., Benach, J.L., Grunwaldt, E. and Davis, J.P. Lyme disease-a tick borne spirochetosis?. Science 1982, 261, 1317-1319
4. Canica, MM, Nato, F., du Merle, L., Mazie, J.C., Baranton, G. and Postic, D. Monoclonal antibodies for identification of Borrelia afzellii sp. nov. associated with cutaneous manifestations of Lyme borreliosis. Scand. J. Infect. Dis. 1993, 25, 441-448
5. Donahue, J.G., Piesman, J. and Spielman, A. Reservoir competence of white-footed mice for Lyme disease spirochetes. Am. J. Trop. Med. Hyg. 1987, 36, 92-96
6. Mather, T.N., Wilson, M.L., Moore, S.I., Ribeiro, J.M. and Spielman, A. Comparing the relative potential of rodents as reservoir of the Lyme disease spirochete (Borrelia burgdorferi). Am. J. Epidemiol. 1989, 130, 143-150
7. Mather, T.N., Telford, S.R.III, Moore, S.I. and Spielman, A. Borrelia burgdorferi and Babesia microtr. efficiency of transmission from reservoirs to vector ticks (Ixodes dammini). Exp. Parasitol. 1990, 70, 55-61
8. Lissman, B.A., Bosler, E.M., Camay, H., Ormistor, B.G. and Benach, J.L. Spirochete-associated arthritis (Lyme disease) in a dog. J. Am. Vet. Med. Assoc. 1984, 185, 219-220
9. Burgess, E.C. Natural exposure of Wisconsin dogs to the Lyme disease spirochete (Borrelia burgdorferi). Lab. Anim. Sci. 1986, 36, 288-290
10. Kornblatt, A.N., Urband, P.H. and Steere, A.C. Arthritis caused by Borrelia burgdorferi in dogs. J. Am. Vet. Med. Assoc. 1985, 186, 960-964
11. Levy, S.A. Lyme borreliosis in domestic animals. Conn. Med. 1989, 53, 352-353
12. Magnarelli, L.A., Anderson, J.F., Schreier, A.B. and Ficke, C.M. Clinical and serologic studies of canine borreliosis. J. Am. Vet. Med. Assoc. 1987, 191, 1089-1094
13. Roush, J.K., Manley, D.A. and Dueland, R.T. Rheumatoid arthritis subsequent to Borrelia burgdorferi infection in two dogs. J. Am. Vet. Med. Assoc. 1989, 195, 951-953
14. Falco, R.C., Smith, H.A., Fish, D. et al. The distribution of canine exposure to Borrelia burgdorferi in a Lyme-disease endemic area. Am. J. Publ. Hlth 1993, 83, 1305-1310
15. Benjamin, J.L., Gorevic, P.D., Halperin, J.J., Volkman, D.J. and Dattwyler, R.J. A perspective on the treatment of Lyme borreliosis. Rev. Infect. Dis. 1989, 11, S1518-1525
16. Dattwyler, R.J., Volkman, D.J., Conaty, S.M., Platkin, S.P. and Luft, B.J. Amoxicillin plus probenecid versus deoxycycline for the treatment of erythema migrans borreliosis. Lancet 1990, 336, 1404-1406
17. Berger, B.W. Treating erythema chronicum migrans of Lyme disease. J. Am. Acad. Dermat. 1986, 15, 459-463
18. Schmidli, J., Hunziker, T, Moesli, P. and Schaad, U.B. Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. J. Infect. Dis. 1988, 158, 905-906
19. Johnson, R.C., Kodner, C. and Russell, M. Passive immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect. Immun. 1986, 53, 713-714
20. Johnson, R.C., Kodner, C. and Russell, M. Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect. Immun. 1986, 54, 897-898
21. Simon, M.M., Schaible, U.E., Wallich, R. and Kramer, M.D. A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease. Immun. Today 1991, 12, 11-16
22. Szczepanski, A. and Benach, J.L. Lyme borreliosis: host responses to Borrelia burgdorferi. Microbiol. Rev. 1991, 55, 21-34
23. Bergström, S., Bundoc, V.G. and Barbour, A.G. Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 1989, 3, 479-486
24. Fikrig, E., Barthoid, S.W., Kantor, F.S. and Flavell, R.A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 1990, 250, 553-556
25. Fikrig, E., Barthoid, S.W., Marcantonio, N., Deponie, K., Kantor, F.S. and Flavell, R.A. Role of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect. Immun. 1992, 60, 657-661
26. Appel, M.J., Allan, S., Jacobson, R.H. et al. Experimental Lyme disease in dogs produces arthritis and persistent infection. J. Infect. Dis. 1993, 167, 651-664
27. Fikrig, E., Telford, S.R., Barthold, S.W., Kantor, F.S., Spielman, A. and Flavell, R.A. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc. Natl. Acad. Sci. USA 1992, 89, 5418-5421
28. Philipp, M.T., Aydintug, M.K., Bohm, R.P.Jr et al. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect. Immun. 1993, 61, 3047-3059
29. Preac-Mursic, V., Wilske, B., Patsouris, E. et al. Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection. Infection 1992, 20, 342-349
30. Schaible, U.E., Kramer, M.D., Eichman, K., Modolell, M., Museteanu, C. and Simon, M.M. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc. Natl. Acad. Sci. USA 1990, 8, 3768-3772
31. Lovrich, S.D., Callister, S.M., Schmitz, J.L., Alder, D.J. and Schell, R.F. Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete. Infect. Immun. 1991, 59, 2522-2528
32. Ma, J. and Coughlin, R.T. A simple, colorimetric microtiter assay for borreliacidal activity of antisera. J. Microbiol. Meth. 1992, 17, 145-153
33. Pavia, C.S., Kissel, V., Bittker, S., Cabello, F. and Levine, S. Antiborrelial activity of serum from rats injected with the Lyme disease spirochete. J. Infect. Dis. 1991, 163, 656-659
34. Šadziene, A., Thompson, P.A. and Barbour, A.G. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J. Infect. Dis. 1992, 167, 165-172
35. Jobe, D.A., Callister, S.M., Lim, L.C.L., Lovrich, S.D. and Schell, R.F. Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi. J. Clin. Microbiol. 1994, 32, 618-622
36. Keller, D., Frederick, F.T., Marks, D.H., Hosbach, D., Erdile, L.F. and Mays, J.P. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. J. Am. Med. Assoc. 1994, 271, 1764-1768
37. Ma, J., Bulger, P.A., Dante, S., Davis, D.v.R., Perilli-Palmer, B. and Coughlin, R.T. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes. J. Infect. Dis. 1995, 171, 909-915
38. Kensil, C.R., Patel, U., Lennick, M. and Marciani, D.J. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J. Immun. 1990, 146, 431-437
39. Ma, J., Bulger, P.A., Davis, D.v.R. et al. Impact of the saponin adjuvant QS-21 and aluminum hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi. Vaccine 1994, 12, 925-932
40. Erdile, L.F., Brandt, M.-A., Warskomski, D.J. et al. Role of attached lipid on immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 1993, 61, 81-90
41. Ma, Y. and Weis, J.J. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 1993, 61, 3843-3853
42. Livingston, P.O. Approaches to augmenting the IgG antibody response to melanoma ganglioside vaccines. Ann. NY Acad. Sci. 1993, 690, 204-213
43. Newman, M.J., Wu, J.-Y, Coughlin, R.T., Seals, C.I., Wyand, M.S. and Kensil, C.R. Immunogenicity and toxicity testing of an experimental HIV vaccine in nonhuman primates. AIDS Res. Hum. Retroviruses 1992, 8, 1413-1418
44. Marciani, D.J., Kensil, C.R., Beltz, G.A., Hung, C.-H., Cronier, J. and Aubert, A. Genetically engineered subunit vaccine against feline leukaemia virus: protective immune response in cats. Vaccine 1991, 9, 89-96
45. Coughlin, R.T., Fish, D., Mather, T.N., Ma, J., Pavia, C. and Bulger, P. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21. J. Infect. Dis. 1995, 171, 1049-1052
46. Ma, J., Gingrich-Baker, C., Franchi, P.M., Bulger, P.A. and Coughlin, R.T. Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi. Infect. Immun. 1995, 63, 2221-2227
47. Ma, J. and Inzana, T.J. Indirect enzyme-linked immunosorbent assay for detection of antibody to a 110-kilodalton hemolysin of Actinobacillus pleuropneumoniae. J. Clin. Microbiol. 1990, 28, 1356-1361
48. Simpson, W.J., Burgdorferi, W., Schrumpf, M.E. et al. Antibody to a 39-kilodalton Borrelia burgdorferi antigen (p39) as a marker for infection in experimentally and naturally inoculated animals. J. Clin. Microbiol. 1991, 29, 236-243
49. Barthold, S.W., Levy, S.A., Fikrig, E., Bochenstedt, L.K. and Smith, A.L. Serological responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection. J. Am. Vet. Med. Assoc. 1995, 207, 1435-1440
50. Kalish, R.A., Leong, J.M. and Steere, A.C. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 1993, 61, 2774-2779
51. Kalish, R.A., Leong, J.M. and Steere, A.C. Early and late antibody responses to full-length and truncated constructs of outer surface proteins A of Borrelia burgdorferi in Lyme disease. Infect. Immun. 1995, 63, 2228-2235
52. Lim, L.C.L., England, D.M., DuChateau, B.K. et al. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect. Immun. 1994, 62, 2825-2833
53. Lim, L.C.L., England, D.M., DuChateau, B.K., Glowacki, N.J. and Schell, R.F. Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect. Immun. 1995, 63, 1400-1408
54. Steere, A.C., Levin, R.E., Molloy, P.J. et al. Treatment of Lyme arthritis. Arthritis Rheum. 1994, 37, 878-888
55. Greene, R.T., Walker, R.J., Nicholson, W.L. et al. Immunoblot analysis of immunoglobulin G response to the Lyme disease agent (Borrelia burgdorferi) in experimentally and naturally exposed dogs. J. Clin. Microbiol. 1988, 26, 648-653
56. Schwan, T.G., Piesman, J., Golde, W.T., Dolan, M.C. and Rosa, P.A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA 1995, 92, 2909-2913
57. Ma, J., Herrig, B. and Salsbury, D.L. Unpublished observation-Fikrig, E., Tao, H., Barthold, S.W. and Flavell, R.A. Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B. Infect. Immun. 1995, 63, 1658-1662
58. Vienecke, R., Neubert, U. and Volkenardt, M. Cross immunity among types of Borrelia burgdorferi. Lancet 1993, 342, 435
59. Coleman, J.L., Rogers, R.C. and Benach, J.L Selection of an escape variant of Borrelia burgdorferi by use of bacteriacidal antibodies to OspB. Infect. Immun. 1992, 60, 3098-3104
60. Šadziene, A., Rosa, P., Hogan, D. and Barbour, A.G. Antibody resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J. Exp. Med. 1992, 176, 799-809
61. Brown, R.N. and Lane, R.S. Lyme disease in California: a novel enzootic transmission cycle of Borrelia burgdorferi. Science 1992, 256, 1439-1442